Diagnostic Histopathology
Volume 14, Issue 12 , Pages 577-585 , December 2008

Role of liver biopsy in disorders of iron metabolism

References 

  1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408
  2. Graham RM, Chua AC, Herbison CE, Olynyk JK, Trinder D. Liver iron transport. World J Gastroenterol. 2007;13:4725–4736
  3. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology. 2007;46:1291–1301
  4. Deugnier Y, Brissot P, Loreal O. Iron and the liver: update 2008. J Hepatol. 2008;48(Suppl. 1):S113–S123
  5. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211–218
  6. Adams PC, Barton JC. Haemochromatosis. Lancet. 2007;370:1855–1860
  7. Fletcher LM, Powell LW. Hemochromatosis and alcoholic liver disease. Alcohol. 2003;30:131–136
  8. Powell EE, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology. 2005;129:1937–1943
  9. Walsh A, Dixon JL, Ramm GA, et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol. 2006;4:1403–1410
  10. Pietrangelo A. Non-HFE hemochromatosis. Hepatology. 2004;39:21–29
  11. Portmann BC, Thompson RJ, Roberts EA, Paterson AC. Genetic and metabolic liver disease. In:  Burt AD,  Portmann BC,  Ferrell LD editor. MacSween’s pathology of the liver. Edinburgh: Churchill Livingstone; 2007;p. 199–326
  12. Sebastiani G, Walker AP. HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol. 2007;13:4673–4689
  13. Whitington PF. Fetal and infantile hemochromatosis. Hepatology. 2006;43:654–660
  14. Scheuer PJ, Lefkowitch JH. Disturbances of copper and iron metabolism. In:  Scheuer PJ,  Lefkowitch JH editor. Liver biopsy interpretation. 7th edn. Philadelphia: Elsevier Saunders; 2006;p. 299–316
  15. Brunt EM. Pathology of hepatic iron overload. Semin Liver Dis. 2005;25:392–401
  16. Batts KP. Iron overload syndromes and the liver. Mod Pathol. 2007;20(Suppl. 1):S31–S39
  17. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol. 2007;13:4755–4760
  18. Olynyk JK, O’Neill R, Britton RS, Bacon BR. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology. 1994;106:674–677
  19. Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there?. J Hepatol. 2005;42:153–154
  20. Wood JC. Diagnosis and management of transfusion iron overload: the role of imaging. Am J Hematol. 2007;82:1132–1135
  21. Deugnier YM, Turlin B, Powell LW, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology. 1993;17:30–34
  22. Olynyk J, Hall P, Sallie R, Reed W, Shilkin K, Mackinnon M. Computerized measurement of iron in liver biopsies: a comparison with biochemical iron measurement. Hepatology. 1990;12:26–30
  23. Brunt EM, Olynyk JK, Britton RS, Janney CG, Di Bisceglie AM, Bacon BR. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol. 2000;95:1788–1793
  24. Hubscher SG. Iron overload, inflammation and fibrosis in genetic haemochromatosis. J Hepatol. 2003;38:521–525
  25. Falize L, Guillygomarc’h A, Perrin M, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology. 2006;44:472–477
  26. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–S50
  27. Deugnier Y. Iron and liver cancer. Alcohol. 2003;30:145–150
  28. Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology. 1993;104:228–234
  29. Morcos M, Dubois S, Bralet MP, Belghiti J, Degott C, Terris B. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Am J Clin Pathol. 2001;116:738–743
  30. Adhoute X, Foucher J, Laharie D, et al. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32:180–187
  31. Deugnier YM, Charalambous P, le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology. 1993;18:1363–1369
  32. Mueller S, Afdhal NH, Schuppan D. Iron, HCV, and liver cancer: hard metal setting the pace?. Gastroenterology. 2006;130:2229–2234
  33. Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat. 2006;13:199–205
  34. Nishina S, Hino K, Korenaga M, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 2008;134:226–238
  35. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis. 2005;25:461–472
  36. Alexander J, Tung BY, Croghan A, Kowdley KV. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study. Liver Int. 2007;27:268–273
  37. Bassett ML. Iron and hepatitis C: beginning to make sense. J Gastroenterol Hepatol. 2007;22:1703–1704
  38. Guyader D, Thirouard AS, Erdtmann L, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2007;46:587–595
  39. Bridle K, Cheung TK, Murphy T, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res. 2006;30:106–112
  40. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology. 1999;117:1155–1163
  41. Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc’h A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol. 2001;116:263–270
  42. Barisani D, Pelucchi S, Mariani R, et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J Hepatol. 2008;49:123–133
  43. Sumida Y, Kanemasa K, Fukumoto K, Yoshida N, Sakai K. Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C. Hepatol Res. 2007;37:932–940
  44. Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology. 2007;46:1071–1080
  45. Deugnier Y, Turlin B, le Quilleuc D, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol. 1997;21:669–675
  46. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997;112:882–888
  47. Brissot P, Loreal O. Role of non-transferrin-bound iron in the pathogenesis of iron overload and toxicity. Adv Exp Med Biol. 2002;509:45–53
  48. Kayali Z, Ranguelov R, Mitros F, et al. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis. Liver Int. 2005;25:41–48
  49. Ko C, Siddaiah N, Berger J, et al. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int. 2007;27:1394–1401

PII: S1756-2317(08)00168-0

doi: 10.1016/j.mpdhp.2008.09.001

Diagnostic Histopathology
Volume 14, Issue 12 , Pages 577-585 , December 2008

Article Tools

* Image Usage & Resolution